COVID-19 Test Maker Investors Seek Final OK For $8.1M Deal

By Sydney Price ( April 25, 2023, 9:16 PM EDT) -- Investors in Chembio Diagnostics Inc., a company that sold now-revoked COVID-19 tests, have asked a New York federal court to give a final OK to an $8.1 million deal to end a lawsuit alleging that shareholders were harmed when the company's tests were taken off the market after being deemed ineffective by the U.S. Food and Drug Administration....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!